In patients with anterior heart attacks, early activation of the BNP-cGMP signaling cascade independently predicted favorable heart remodeling and fewer major cardiac events over nearly 10 years of follow-up.
74% lower MACCE riskPatients with left ventricular reverse remodeling had a 74% lower risk of major cardiac and cerebrovascular events over nearly 10 years of follow-up (HR 0.256).
What the researchers found
ProBNP and estimated mature BNP from 12 hours to 5 days post-AMI, and cGMP from immediately post-intervention to 3 days, were independent predictors of left ventricular reverse remodeling.
Why it matters
Natriuretic peptides are usually viewed as passive markers of heart failure severity. This study suggests they may actually drive cardiac recovery after a heart attack — shifting the narrative from BNP as a diagnostic tool to BNP as a therapeutic pathway worth enhancing.
The numbers in context
67 patients with first anterior AMI. Median age 64 years, 76% male. Measured BNP-cGMP cascade components prospectively.
How the study worked
Prospective cohort study of 67 anterior AMI patients with serial blood sampling of ANP, BNP molecular forms, and cGMP from immediately post-PPCI through 10 months, with cardiac MRI assessment and median 9.9-year clinical follow-up.
Who was studied
Patients with first anterior acute myocardial infarction (median age 64, 76% male)
What this study cannot tell us
Small sample size (67 patients) from a single center limits generalizability. The study is observational and cannot prove that BNP-cGMP activation causes reverse remodeling. The median split for defining LVRR groups is somewhat arbitrary. The cohort was predominantly male (76%).
How to read the evidence
This is a prospective cohort study with nearly 10 years of follow-up and rigorous serial biomarker measurement. However, the small sample size (n=67) and single-center design limit the evidence strength.
When this study was published
Published in 2025, based on a long-term prospective cohort with median 9.9-year follow-up.
The bigger picture
This study adds to growing evidence that natriuretic peptides are not just biomarkers but active participants in cardiac repair. If the BNP-cGMP axis can be therapeutically augmented early after a heart attack — through drugs like sacubitril that prevent BNP breakdown — it might improve long-term heart recovery outcomes.
Questions still open
- Could administering neprilysin inhibitors (sacubitril) early after heart attack enhance protective BNP-cGMP signaling?
- Do patients with genetically higher BNP production have better cardiac recovery after AMI?
- Can early cGMP measurement be added to routine post-AMI risk stratification?
Common questions
Is BNP good or bad after a heart attack?
What is left ventricular reverse remodeling?
Read the original research
Association between left ventricular reverse remodelling and the B-type natriuretic peptide-cGMP cascade after anterior acute myocardial infarction.
Open heart, 12(1)
Citation
Arai, Marina; Asaumi, Yasuhide; Honda, Satoshi; Ogata, Soshiro; Kiyoshige, Eri; Nakao, Kazuhiro; Miura, Hiroyuki; Morita, Yoshiaki; Nakashima, Takahiro; Murai, Kota; Iwai, Takamasa; Sawada, Kenichiro; Matama, Hideo; Fujino, Masashi; Takahama, Hiroyuki; Yoneda, Shuichi; Takagi, Kensuke; Otsuka, Fumiyuki; Kataoka, Yu; Nishimura, Kunihiro; Noguchi, Teruo; Minamino, Naoto; Yasuda, Satoshi. (2025). Association between left ventricular reverse remodelling and the B-type natriuretic peptide-cGMP cascade after anterior acute myocardial infarction.. Open heart, 12(1). https://doi.org/10.1136/openhrt-2024-002927